Introduction: Chinese is the world's largest ethnic group but few health-related quality of life (HRQoL) measures have been tested on them. The aim of this study was to determine if the standard SF-12 was valid and equivalent for a Chinese population. Methods: The SF-36 data of 2410 Chinese adults randomly selected from the general population of Hong Kong (HK) were analysed. The Chinese (HK) specific SF-12 items and scoring algorithm were derived from the HK Chinese population data by multiple regressions. The SF-36 PCS and MCS scores were used as criteria to assess the content and criterion validity of the SF-12. The standard and Chinese (HK) specific SF-12 PCS and MCS scores were compared for equivalence. Results: The standard SF-12 explained 82% and 89% of the variance of the SF-36 PCS and MCS scores, respectively, and the effect size differences between the standard SF-36 and SF-12 scores were less than 0.3. Six of the Chinese (HK) specific SF-12 items were different from those of the standard SF-12, but the effect size differences between the Chinese (HK) specific and standard SF-12 scores were mostly less than 0.3. Conclusions: The standard SF-12 was valid and equivalent for the Chinese, which would enable more Chinese to be included in clinical trials that measure HRQoL.
Introduction
Chinese make up nearly a quarter of the world's population. They should be included in global and cross-cultural clinical trials but this is often not possible in studies that measure health-related quality of life (HRQoL) because of language and cultural barriers. Most HRQoL measures are in English and originate from the Western culture, so they need to be translated and validated before they can be applied to the Chinese. The Chinese (Hong Kong) translation of the MOS 36-item Short Form Health Survey (SF-36) and its physical and mental health summary (PCS and MCS) Scales have been shown to be valid and equivalent for the Chinese [1] [2] [3] [4] [5] , but the length of the SF-36 limits its acceptability in some clinical trials that need to measure a number of outcomes. The standard SF-12 Health Survey (SF-12), an abbreviated form of the SF-36 that yields the PCS and MCS scores, is becoming a popular HRQoL measure in clinical trials because it can be completed in a few minutes [6, 7] .
The items and scoring algorithm of the standard SF-12 were derived from data of a US general population survey in 1990 [6] [7] [8] . The standard SF-12 PCS and MCS scores are norm-based on the US general population whose mean is 50 and standard deviation (SD) is 10 [6, 9] . The 12 items include two from each of the physical functioning, role-physical, role-emotional and mental health scales and one item from each of the bodily pain, general health, vitality and social functioning scales of the SF-36. The items were selected by multiple regressions in order to explain the largest proportion of the total variance in the SF-36 PCS and MCS scores. The response to each item is weighted separately by the PCS and MCS regression coefficient and then summated to give the standard SF-12 PCS and MCS scores, respectively.
A small number and weighting of items may make a HRQoL measure more culture-sensitive [10, 11] . All previous studies on the validity and equivalence of the standard SF-12 were carried out in Caucasian populations [8, 12] . There was very little data from any Chinese or Asian population whose cultures are quite different from those of the West. The rank orders by item mean of three (PF9, GH3 and RE3) SF-36 items were found to be different between the HK Chinese and US populations [1] . Although the differential item functioning (DIF) of a few items did not affect the validity of the SF-36 Scales that summated all the items without weighting [1, 13] , they may have an effect on the validity and equivalence of the much shorter standard SF-12.
The aim of this study was to determine if the standard SF-12 was valid and equivalent for the Chinese population of Hong Kong, or whether a Chinese (HK) specific SF-12 was needed. The standard SF-12 is valid if it really measures the SF-36 PCS and MCS scores, which are what it purports to measure. The selected items should be representative and adequate in explaining the SF-36 PCS and MCS scores (content validity), and the SF-12 should give similar PCS and MCS scores as the SF-36 (criterion validity). The standard SF-12 is equivalent if no more than three of the 12 items selected specifically from the Chinese (HK) population were different from those of the standard SF-12, as that found in other countries (item equivalence) [8] ; and if there is no important difference between the results of the Chinese (HK) specific and standard scoring algorithms (measurement equivalence) [8, 14, 15] .
Methods
Data of 2410 Chinese adults randomly selected from the general population of Hong Kong that were collected in the Chinese (Hong Kong) SF-36 norming survey in 1998 were used for analysis in this study. The detailed sampling and data collection methods have been described in previous papers [16, 17] . All subjects answered the Chinese (Hong Kong) translation of the SF-36 and a structured questionnaire on sociodemographic data. Each subject was also asked to indicate whether he/she had ever been diagnosed by a doctor to have hypertension, diabetes mellitus, heart disease, stroke, chronic pulmonary disease, chronic joint disease, psychological illness or any other chronic disease. A subject was classified as not having any chronic disease if the responses to these chronic disease questions were all negative. Table 1 shows that the sociodemographic characteristics of the subjects were similar to those of the general adult population in Hong Kong [18] . The sample was comparable to the US population sample [19] from which the standard SF-12 was derived in mean age (42.9 vs. 43.6 years) and sex distribution (47.8% vs. 48% males).
The Chinese (HK) specific SF-12 items were selected by multiple regressions of the Chinese (HK) specific SF-36 PCS and MCS scores derived from the HK Chinese adult population [3] , based on the criteria of the International Quality of Life Assessment (IQOLA) Project for cross-cultural adaptation of the SF-12 [8] . The Chinese (HK) specific PCS and MCS regression constants and coefficients for each item response were obtained by regressing the Chinese (HK) specific SF-36 PCS and MCS scores on the Chinese (HK) specific item scores. The SAS programme was used for the multiple regressions analyses. The SPSS Programme for Windows 10.0 (SPSS Inc. Chicago, IL, USA) was used for all other data analyses.
The standard SF-12 PCS and MCS scores were calculated by the standard algorithm described in the SF-12 Manual [6] . The Chinese (HK) specific and standard mean SF-12 PCS and MCS scores were determined for all subjects and by self-reported chronic disease groups.
Content validity was assessed by the proportion of total variance of the SF-36 PCS and MCS scores explained by the SF-12 PCS and MCS, and P90% was the expected standard [6, 8] . It was further assessed by Pearson correlations between the SF-12 and SF-36 PCS and MCS scores and the expected standard was P0.9 [6, 8] . Effect size difference between corresponding SF-12 and SF-36 PCS and MCS scores was used to determine if the SF-12 gave similar or different results from those of the SF-36 (Criterion validity). Effect size difference between the SF-36 and SF-12 scores was calculated by dividing their difference by the standard deviation (SD) of the SF-36 summary score.
Measurement equivalence between the standard and Chinese (HK) specific SF-12 was first assessed by Pearson correlations (expected standard P0.9) and then the effect size differences between the standard and Chinese (HK) specific scores. The effect size difference was calculated by dividing the difference between the corresponding SF-12 scores by the SD of the Chinese (HK) specific SF-12 score. The standard and Chinese (HK) SF-12 scores were also compared by chronic disease groups in order to determine if they performed differently in different groups. A spectrum of chronic diseases (Heart, chronic pulmonary, psychological and chronic joint) that are known to affect HRQoL were used as tracer conditions [20] .
There is no consensus on what the minimally important difference (MID) in HRQoL scores should be. Kazis et al. showed that the effect size changes in scores measured by the Arthritis Impact Measurement Scale were mostly between 0.3 and 0.5 in the treatment group [21] ; and Wyrwich showed that the MID of the Chronic Heart Failure Questionnaire scores corresponded to effect size changes of 0.34-0.37 [22] . We therefore adopted Cohen's moderate effect size of 0.3-0.5 as the MID in this study [23, 24] .
Results

The Chinese (HK) specific SF-12 PCS and MCS scales
First forward stepwise regressions of the Chinese (HK) specific SF-36 PCS and MCS scores on the SF-36 items selected two items each from the physical functioning (PF1, PF8) and mental health (MH3, MH4) scales, and one item each from the role-physical (RP3), bodily pain (BP1), social functioning (SF1) and role-emotional (RE3) scales. The second forward stepwise regressions, with the general health item (GH1) and the above items forced into the model, selected the remaining items (RP2, VT4 and RE1) that explained the greatest variance of the HK Chinese specific SF-36 PCS and MCS scores. It is an IQOLA criterion that GH1 should be included in all versions of SF-12 because it is an item common to many HRQoL measures [8] . Table 2 shows the Chinese (HK) specific SF-12 items, in comparison with the standard SF-12 items. The items that were different are shown in bold. The numbers in brackets correspond to the question numbers in the SF-36 Health Survey. Table 3 shows the regression coefficients of the Chinese (HK) specific SF-12 items and those of the 
Content and criterion validity of the SF-12 PCS and MCS
The R 2 in Table 3 indicates the proportion of total variance in the SF-36 PCS or MCS score that was explained by the corresponding SF-12 summary score. The standard SF-12 PCS and MCS explained 82% and 89% of the total variances of the standard SF-36 PCS and MCS, respectively. The Chinese (HK) specific SF-12 PCS and MCS explained 88% and 90% of the total variances of the Chinese (HK) specific SF-36 PCS and MCS, respectively. Table 4 shows the correlations between the SF-12 and SF-36 PCS and MCS scores. The correlations between the corresponding SF-36 and SF-12 summary scores all reached the expected standard of 0.9.
The mean and standard deviation (SD) of the Chinese (HK) specific and standard SF12 and SF-36 PCS and MCS scores of the whole sample and by self-reported chronic disease groups are shown in Table 5 . The effect size differences (effect size 1) between corresponding SF-36 and SF-12 scores were all less than 0.3.
Measurement equivalence between the chinese (HK) specific and standard SF-12
As shown in Table 4 , the correlations between the corresponding standard and Chinese (HK) specific SF-12 PCS and MCS scores were just short of 0.9. The standard and Chinese (HK) specific SF-12 scores are compared in Table 5 . The mean standard SF-12 PCS and MCS for the overall HK Chinese population were 50.2 and 48.4, respectively, which were similar to the US general population means of 50. The Chinese (HK) specific and standard SF-12 detected similar significant differences between each chronic disease group and the 'no chronic disease' group. The largest difference between the Chinese (HK) specific and standard SF-12 scoring algorithms was the PCS score of people reporting heart diseases, with an effect size of 0.36.
Discussion
The standard SF-12 did not satisfy the criterion on item equivalence for the Chinese population in Hong Kong. Six items of the Chinese (HK) specific SF-12 were different from those of the standard SF-12, suggesting some cultural differences in differential item functioning (DIF) of the SF-36 between the Chinese and US populations [13, 25] . The number of items that were different between the standard and Chinese (HK) SF-12 was larger than those found in nine European countries, probably because there are more differences between the Chinese than European cultures and the US culture [8] . No other country has selected PF1, BP1 and RE1 as the best SF-12 items, which may reflect DIF that is unique to the Chinese culture. However, one must be cautious in generalising the results from this study to other Chinese populations because the social system and people's life style in Hong Kong are very different from those of Mainland China and other Chinese societies. Quality of life assessment is influenced not only by one's ethnicity; it is also affected by social norms. Chinese populations living in different parts of the world may have developed different social expectations and standards of quality of life although they have the same cultural origin. Studies comparing the population specific SF-12 items between Chinese populations in Hong Kong, Mainland China, Taiwan, Singapore and Western countries could provide interesting information on whether DIF is ethnic or population specific. The standard SF-12 PCS explained only 82% of the total variance of the SF-36 PCS score because three items (two from the physical functioning and one from the bodily pain scales) that contributed strongly to the standard SF-12 PCS score were not the best items for the HK Chinese population. Despite this deficiency, there were very strong correlations (P0.9) between the standard SF-12 and SF-36 PCS and MCS scores, and there were very small differences (effect size <0.3) between corresponding SF-36 and standard SF-12 scores in different groups of subjects. The findings supported the content and criterion validity of the standard SF-12 for the Chinese population in Hong Kong.
The mean standard SF-12 PCS and MCS scores of the HK subjects were only 0.2 and 1.6 points different from the US population mean of 50, suggesting that the standard SF-12 was equivalent for this Chinese population. Pooling of the standard SF-12 data between the US and HK Chinese populations may be possible. As expected, the Chinese (HK) specific SF-12 had better psychometric properties than the standard SF-12, which could imply better sensitivity and responsiveness for the Chinese. However, the Chinese (HK) specific SF-12 did not seem to differentiate between 'chronic disease' and 'no chronic disease' groups better than the standard SF-12. The differences in the SF-12 scores obtained by the two scoring algorithms were all smaller than the minimally important difference (MID). Small improvements in cultural specificity and psychometric properties may not necessarily translate to real advantages in practice, and they have to be balanced against a decrease in international comparability. This point has also been highlighted by Skevington et al. [26, 27] , who found that country specific items did not significantly improve the performance of the standard WHO Quality of Life (WHOQoL) Assessment Form.
A major limitation of this cross-sectional study was that it could not assess the responsiveness of the standard and Chinese (HK) specific SF-12. The information on the sensitivity of the SF-12 in discriminating between chronic disease groups was also limited by possible errors in subjects' selfreporting. Further studies are required to determine the responsiveness and sensitivity of the standard SF-12 and Chinese (HK) specific SF-12 as outcome measures in clinical trials.
It should also be pointed out that subjects in this study answered the full SF-36 Health Survey from which the data of the standard and Chinese (HK) specific SF-12 were extracted. Further studies should be carried out to determine if people would answer the standard and Chinese (HK) specific SF-12 differently if they are presented as two independent stand-alone surveys instead of embedded items of a longer questionnaire.
Conclusions
This was the first study to show that the standard SF-12 Health Survey was valid and equivalent for a Chinese population. The standard SF-12 items and scoring algorithm are recommended for the Chinese so that cross-cultural comparison and pooling of data are possible. The Chinese (HK) specific SF-12 showed better psychometric properties than the standard SF-12, thus, the Chinese (HK) specific SF-12 may have a place in small local studies that require a more sensitive HRQoL measure instead of international comparability.
We hope our findings will encourage more studies of the standard SF-12 in Chinese populations in other parts of China, Singapore and Western countries to provide more evidence in support of the use of this popular HRQoL measure on the world's largest ethnic group, so that Chinese can be included in more clinical trials. Further research on the population specific SF-12 items in different Chinese populations could provide interesting information on whether differential item functioning is ethnic or population specific.
